Hadas Nicole R.

Average Profitability
3.18%
Insider Buys Quantity
1
Insider Buys Sum
$119,000.00
Insider Sells Quantity
23
Insider Sells Sum
$955,460.85

Insider Activity of Hadas Nicole R.

According to the SEC Form 4 filings, Hadas Nicole R., being in a position of

  1. SVP, Chief Legal Officer at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25401 share for $35,844,
    over all time since 2014-03-25, has bought 7000 shares for $119,000, and sold 202493 shares for $955,461.

The largest purchase of all time was on 2014-03-25 and amounted to 7000 shares of Akebia Therapeutics, Inc. for $119,000.

The largest sale of all time was on 2017-10-02 and amounted to 15606 shares of Akebia Therapeutics, Inc. for $310,377.

Biography of Hadas Nicole R.

No biography is available at this moment.

2024-05-13SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
12,016
0.0056%
$1.26$15,140+7.03%
2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
5,974
0.0032%
$1.58$9,439-10.83%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
7,411
0.0036%
$1.52$11,265-14.63%
2023-05-25SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
63,186
0.0346%
$1.22$77,270+3.31%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
13,034
0.0068%
$0.88$11,437+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
6,677
0.0036%
$0.81$5,430+38.48%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
14,507
0.0082%
$2.17$31,490-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
6,555
0.0036%
$2.15$14,125-81.02%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
1,060
0.0007%
$3.40$3,604-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
14,285
0.0094%
$3.40$48,513-14.71%
2020-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Legal Officer
7,050
0.0054%
$8.70$61,335-34.16%
2017-10-02SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
15,606
0.0326%
$19.89$310,377-45.25%
2017-07-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,108
0.0065%
$14.26$44,313-0.51%
2017-04-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,112
0.0078%
$9.18$28,560+64.77%
2017-01-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,620
0.0097%
$10.49$37,976
2016-10-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,112
0.0082%
$8.95$27,867
2016-07-05SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,114
0.0082%
$7.47$23,251+21.67%
2016-04-04SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,112
0.0081%
$9.41$29,284-7.02%
2016-01-04SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
3,622
0.0096%
$12.28$44,478-32.72%
2015-10-02SaleAkebia Therapeutics, Inc.
AKBA
SVP, General Counsel, Sec.
2,968
0.0099%
$8.67$25,720-11.81%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.